Medical device maker Guidant has been under the gun for some time, facing angry shareholders because of the company's sliding stock price and federal regulators because of electrical flaws with Guidant's implantable defibrilators and pacemakers. Now the company has announced that it will withdraw from the market their Xience V cardiac stent, a drug-coated metal mesh cylinder used to hold open clogged arteries in heart disease patients. Guidant cited a 1% failure rate in their decision to pull the product.

More here.

-- MDT